 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/09/2019 |
$2.82 |
$2.93 |
$2.77 |
$2.91 |
61.40K | | 09/10/2019 |
$2.93 |
$3.32 |
$2.86 |
$3.23 |
250.80K | | 09/11/2019 |
$3.30 |
$3.49 |
$3.25 |
$3.41 |
155.50K | | 09/12/2019 |
$3.45 |
$3.45 |
$2.95 |
$3.16 |
111.10K | | 09/13/2019 |
$3.23 |
$3.35 |
$3.13 |
$3.27 |
79.00K |
|
|
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with unmet medical need. Co.'s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a fully taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of various neuroendocrine disorders. | |
|
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on September 09, 2019, ACER opened at $2.82, traded as high as $2.93 and as low as $2.77, and closed at $2.91. Trading volume was a total of 61.40K shares. On September 10, 2019, ACER opened at $2.93, traded as high as $3.32 and as low as $2.86, and closed at $3.23. Trading volume was a total of 250.80K shares. On September 11, 2019, ACER opened at $3.30, traded as high as $3.49 and as low as $3.25, and closed at $3.41. Trading volume was a total of 155.50K shares. On September 12, 2019, ACER opened at $3.45, traded as high as $3.45 and as low as $2.95, and closed at $3.16. Trading volume was a total of 111.10K shares. On September 13, 2019, ACER opened at $3.23, traded as high as $3.35 and as low as $3.13, and closed at $3.27. Trading volume was a total of 79.00K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/16/2009 |
|
| End date: |
09/13/2019 |
|
| Start price/share: |
$41.77 |
|
| End price/share: |
$3.27 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-92.17% |
|
| Average Annual Total Return: |
-22.49% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$783.21 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 09/09/2019 | $2.91 | | 09/10/2019 | $3.23 | | 09/11/2019 | $3.41 | | 09/12/2019 | $3.16 | | 09/13/2019 | $3.27 |
|
|
